Asymptomatic Changes in Cardiac Function Can Occur in DCIS Patients Following Treatment with HER-2/neu Pulsed Dendritic Cell Vaccines

BACKGROUND: Targeting HER-2/neu with Trastuzumab has been associated with development of cardiac toxicity. METHODS: Twenty-seven patients with ductal carcinoma in situ (DCIS) of the breast completed an IRB approved clinical trial of a HER-2/neu targeted dendritic cell based vaccine. Four weekly vacc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bahl, Susan, Roses, Robert, Sharma, Anupama, Koldovsky, Ursula, Xu, Shuwen, Weinstein, Susan, Nisenbaum, Harvey, Fox, Kevin, Pasha, Theresa, Zhang, Paul, Araujo, Louis, Carver, Joseph, Czerniecki, Brian J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758542/
https://ncbi.nlm.nih.gov/pubmed/19800453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjsurg.2009.06.014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller